Close

Analyst Ratings for Onconova Therapeutics (ONTX) [Buys]

ONTX Rating Summary

  |   Expand Research on ONTX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7 / 10   Percentile Rank: 75%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/21/2023 H.C. Wainwright Joseph Pantginis Upgrade Buy
(N/A)
11.00
(N/A)
0.70
(1.00)
42.86% Details
3/1/2022 Ladenburg Thalmann Ahu Demir New Coverage Buy
(N/A)
7.00
(N/A)
1.62
(1.00)
-38.27% Details